The movement to limit face recognition tech might finally get a win
By Tate Ryan-Mosley,
MIT Technology Review
| 07. 20. 2023
Just four years ago, the movement to ban police departments from using face recognition in the US was riding high. By the end of 2020, around 18 cities had enacted laws forbidding the police from adopting the technology. US lawmakers proposed a pause on the federal government’s use of the tech.
In the years since, that effort has slowed to a halt. Five municipal bans on police and government use passed in 2021, but none in 2022 or in 2023 so far, according to a database from the digital rights group Fight for the Future. Some local bans have even been partially repealed, and today, few seriously believe that a federal ban on police use of face recognition could pass in the foreseeable future. In the meantime, without legal limits on its use, the technology has only grown more ingrained in people’s day-to-day lives.
However, in Massachusetts there is hope for those who want to restrict police access to face recognition. The state’s lawmakers are currently thrashing out a bipartisan state bill that seeks to limit police use of...
Related Articles
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By George Janes, BioNews | 04.20.2026
New regulations in sperm donation are being implemented by Belgium's Federal Agency for Medicines and Health Products (FAMHP), following revelations regarding the use of sperm carrying a cancer-causing mutation, and widespread breaches of donor limits.
In 2025, it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...